Olivier Colliot

Olivier Colliot

Auto-generated profile, based on publicly available information

Olivier Colliot

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Medical Image Analysis
Verified
Journal Article
Closed access
JWJunhao Wen
Junhao Wen
ETElina Thibeau-Sutre
Elina Thibeau-Sutre
MDMauricio Diaz-Melo
Mauricio Diaz-Melo
JSJorge Samper-González
Jorge Samper-González
ARAlexandre Routier
Alexandre Routier
OCOlivier Colliot
Olivier Colliot

1 October 2009 in NeuroImage
Verified
Journal Article
Closed access
EGEmilie Gerardin
Emilie Gerardin
GCGaël Chételat
Gaël Chételat
MCMarie Chupin
Marie Chupin
RCRémi Cuingnet
Rémi Cuingnet
BDBéatrice Desgranges
Béatrice Desgranges
OCOlivier Colliot
Olivier Colliot

1 December 2018 in NeuroImage
Verified
Journal Article
Closed access
JSJorge Samper-González
Jorge Samper-González
NBNinon Burgos
Ninon Burgos
SBSimona Bottani
Simona Bottani
SFSabrina Fontanella
Sabrina Fontanella
PLPascal Lu
Pascal Lu
OCOlivier Colliot
Olivier Colliot

13 August 2021 in Frontiers in Neuroinformatics
Verified
Journal Article
Open access
ARAlexandre Routier
Alexandre Routier
NBNinon Burgos
Ninon Burgos
MDMauricio Díaz
Mauricio Díaz
MBMichael Bacci
Michael Bacci
SBSimona Bottani
Simona Bottani
OCOlivier Colliot
Olivier Colliot
We present Clinica (www.clinica.run), an open-source software platform designed to make clinical neuroscience studies easier and more reproducible. Clinica aims for researchers to (i) spend less time on data management and processing, (ii) perform reproducible evaluations of their methods, and (iii) easily share data and results within their institution and with external collaborators. The core of Clinica is a set of automatic pipelines for processing and analysis of multimodal neuroimaging data (currently, T1-weighted MRI, diffusion MRI, and PET data), as well as tools for statistics, machine learning, and deep learning. It relies on the brain imaging data structure (BIDS) for the organization of raw neuroimaging datasets and on established tools written by the community to build its pipelines. It also provides converters of public neuroimaging datasets to BIDS (currently ADNI, AIBL, OASIS, and NIFD). Processed data include image-valued scalar fields (e.g., tissue probability maps), meshes, surface-based scalar fields (e.g., cortical thickness maps), or scalar outputs (e.g., regional averages). These data follow the ClinicA Processed Structure (CAPS) format which shares the same philosophy as BIDS. Consistent organization of raw and processed neuroimaging files facilitates the execution of single pipelines and of sequences of pipelines, as well as the integration of processed data into statistics or machine learning frameworks. The target audience of Clinica is neuroscientists or clinicians conducting clinical neuroscience studies involving multimodal imaging, and researchers developing advanced machine learning algorithms applied to neuroimaging data.

1 January 2014 in NeuroImage: Clinical
Verified
Journal Article
Open access
CBClaire Boutet
Claire Boutet
MCMarie Chupin
Marie Chupin
SLStéphane Lehéricy
Stéphane Lehéricy
LMLinda Marrakchi-Kacem
Linda Marrakchi-Kacem
SEStéphane Epelbaum
Stéphane Epelbaum
OCOlivier Colliot
Olivier Colliot
In Alzheimer's disease (AD), the hippocampus is an early site of tau pathology and neurodegeneration. Histological studies have shown that lesions are not uniformly distributed within the hippocampus. Moreover, alterations of different hippocampal layers may reflect distinct pathological processes. 7 T MRI dramatically improves the visualization of hippocampal subregions and layers. In this study, we aimed to assess whether 7 T MRI can detect volumetric changes in hippocampal layers in vivo in patients with AD. We studied four AD patients and seven control subjects. MR images were acquired using a whole-body 7 T scanner with an eight channel transmit-receive coil. Hippocampal subregions were manually segmented from coronal T2*-weighted gradient echo images with 0.3 × 0.3 × 1.2 mm3 resolution using a protocol that distinguishes between layers richer or poorer in neuronal bodies. Five subregions were segmented in the region of the hippocampal body: alveus, strata radiatum, lacunosum and moleculare (SRLM) of the cornu Ammonis (CA), hilum, stratum pyramidale of CA and stratum pyramidale of the subiculum. We found strong bilateral reductions in the SRLM of the cornu Ammonis and in the stratum pyramidale of the subiculum (p < 0.05), with average cross-sectional area reductions ranging from -29% to -49%. These results show that it is possible to detect volume loss in distinct hippocampal layers using segmentation of 7 T MRI. 7 T MRI-based segmentation is a promising tool for AD research.

30 June 2020 in Current Opinion in Neurology
Verified
Journal Article
Closed access
NBNinon Burgos
Ninon Burgos
OCOlivier Colliot
Olivier Colliot
Purpose of review: Machine learning is an artificial intelligence technique that allows computers to perform a task without being explicitly programmed. Machine learning can be used to assist diagnosis and prognosis of brain disorders. Although the earliest articles date from more than ten years ago, research increases at a very fast pace. Recent findings: Recent works using machine learning for diagnosis have moved from classification of a given disease versus controls to differential diagnosis. Intense research has been devoted to the prediction of the future patient state. Although a lot of earlier works focused on neuroimaging as data source, the current trend is on the integration of multimodal data. In terms of targeted diseases, dementia remains dominant but approaches have been developed for a wide variety of neurological and psychiatric diseases. Summary: Machine learning is extremely promising for assisting diagnosis and prognosis in brain disorders. Nevertheless, we argue that key challenges remain to be addressed by the community for bringing these tools in clinical routine: good practices regarding validation and reproducible research need to be more widely adopted; extensive generalization studies are required; interpretable models are needed to overcome the limitations of black-box approaches.